Current Assets
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)
Vertex Pharmaceuticals AFS and Trading Securities - Unrealized Loss Position (>=12 Months) remained flat by 0.0% to $100.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $100.00K to $100.00K. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026May 5, 2026
How to read this metric
A high or increasing value suggests potential long-term credit risk or persistent valuation challenges in the portfolio.
Detailed definition
The fair value of debt securities classified as available-for-sale or trading that have been in an unrealized loss posit...
Peer comparison
Used by analysts to evaluate the quality and long-term health of an insurer's investment portfolio.
Metric ID:
afs_debt_securities_unrealized_loss_12m_plusHistorical Data
10 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $53.80M | $3.50M | $100.00K | $100.00K | $100.00K | $100.00K | $100.00K |
| QoQ Change | — | — | — | — | -93.5% | -97.1% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | — | -99.8% | -97.1% | +0.0% | +0.0% |
Range$0.00 – $53.80M
Avg YoY Growth-49.2%
Median YoY Growth-48.6%
Current Streak4 quarters growth
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's afs and trading securities - unrealized loss position (>=12 months)?
- Vertex Pharmaceuticals (VRTX) reported afs and trading securities - unrealized loss position (>=12 months) of $100.00K in Q1 2026.
- How has Vertex Pharmaceuticals's afs and trading securities - unrealized loss position (>=12 months) changed year-over-year?
- Vertex Pharmaceuticals's afs and trading securities - unrealized loss position (>=12 months) decreased by 0.0% year-over-year, from $100.00K to $100.00K.
- What does afs and trading securities - unrealized loss position (>=12 months) mean?
- The current market value of debt investments that have been worth less than their cost for a year or more.